Webinar: Educating Health Care Professionals About Mesothelioma

Advocacy
Reading Time: 3 mins
Publication Date: 03/11/2022
Fact Checked
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Reviewed

Asbestos.com is the nation’s most trusted mesothelioma resource

The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.

Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.

More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.

About The Mesothelioma Center at Asbestos.com

  • Assisting mesothelioma patients and their loved ones since 2006.
  • Helps more than 50% of mesothelioma patients diagnosed annually in the U.S.
  • A+ rating from the Better Business Bureau.
  • 5-star reviewed mesothelioma and support organization.
Learn More About Us

Testimonials

"My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family."
Lashawn
Mesothelioma patient’s daughter
  • Google Review Rating
  • BBB Review Rating

How to Cite Asbestos.com’s Article

APA

Miller, M. (2022, March 21). Webinar: Educating Health Care Professionals About Mesothelioma. Asbestos.com. Retrieved January 26, 2023, from https://www.asbestos.com/blog/2022/03/11/webinar-health-professionals-mesothelioma/

MLA

Miller, Missy. "Webinar: Educating Health Care Professionals About Mesothelioma." Asbestos.com, 21 Mar 2022, https://www.asbestos.com/blog/2022/03/11/webinar-health-professionals-mesothelioma/.

Chicago

Miller, Missy. "Webinar: Educating Health Care Professionals About Mesothelioma." Asbestos.com. Last modified March 21, 2022. https://www.asbestos.com/blog/2022/03/11/webinar-health-professionals-mesothelioma/.

Specialists with the highly regarded Kaiser Permanente Northern California Regional Mesothelioma Program will be featured in a live webinar on March 17 targeting the educational needs of health care professionals.

The program will be hosted by the Medical Outreach team at Asbestos.com and is designed to help those in the medical profession better understand mesothelioma, a rare and aggressive cancer.

Thoracic surgeon Dr. Jeffrey Velotta and medical oncologist Dr. J. Marie Suga will be presenting throughout the virtual webinar, which is titled “Understanding Mesothelioma Treatment Options in 2022: Guide to a Better Future.”

Interested individuals can RSVP to medicaloutreach@asbestos.com for details on attending the event, which will be held from 12:30-1:30 p.m. PST on Thursday.

Mesothelioma Experts to Share Expertise

The activity agenda will include the following:

  • Activity overview and speaker introductions
  • Information about malignant pleural mesothelioma and current guideline recommendations
  • Thoracic surgery treatment advances for MPM
  • Oncology treatment advances for MPM, including the roles of local, immuno and systemic therapies
  • Overview of Kaiser Permanente Northern California Regional Mesothelioma Program
  • Practical patient type referral and treatment collaboration of MPM patients
  • Question and answer session
  • Conclusion

Participants Include Kaiser Permanente Specialists 

The Mesothelioma Center at Asbestos.com is proud to collaborate with an elite facility such as Kaiser Permanente and specialists Velotta and Suga in hosting this event.

Velotta has earned his reputation as one of the finest mesothelioma surgeons practicing today. He trained at Brigham and Women’s Hospital in Boston under the guidance of legendary mesothelioma treatment pioneer Dr. David Sugarbaker.

Suga has been heralded for helping advance thoracic cancer treatment as medical director of the Kaiser Permanente Clinical Trials Program.

Doctors, nurses and nurse practitioners around the country rarely see a patient with pleural mesothelioma, a difficult-to-diagnose cancer even for a trained oncologist, creating the need for a webinar such as this.

Time is critical for a patient showing early signs of this disease caused by asbestos exposure. To properly diagnose it and get the patient to specialists such as Velotta could make a world of difference in terms of survival, particularly as recent advances in treatment are being discovered.

Goal of the Webinar Is Education

At the conclusion of the webinar, participants should be better able to:

  • Identify signs and symptoms that may help diagnostic tests and procedures.
  • Identify occupational and environmental hazards that increase susceptibility to disease.
  • Apply evidence-based treatment strategies.
  • Confidently communicate and streamline patient referrals for second opinions and treatment plans with Kaiser Permanente Northern California Regional Program.

This webinar is about educating the medical community for the benefit of patients who can be diagnosed earlier when mesothelioma is more treatable. It is about getting help from a mesothelioma specialist who may treat the disease more effectively.

Participants will be encouraged to engage in case-based discussions and critical deliberations on the state of clinical findings and management plan options for their patients.